Home / Disease / News

01/05/03

Thai AIDS trial faces delay

Republish

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Send to a friend

The details you provide on this page will not be used to send unsolicited email, and will not be sold to a 3rd party. See privacy policy.

The largest planned AIDS vaccine trial to date, due to take place in Thailand, is to be delayed by at least a year.

Production problems and setbacks in renovating health centres and clinics in preparation for the trial have caused the delay.

The trial — which aims to test a pair of vaccines developed by Aventis Pasteur and VaxGen in 16,000 Thai participants — is only the second efficacy trial for an AIDS vaccine. The Thai ministry of health says that, despite the delays, volunteer recruitment for the trial should start in September.

Reference: Science, 17 January 2003